Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 4, 2002

Premium

Peter Chambre, former COO at Celera Genomics, will join London-based Cambridge Antibody Technology as CEO in early April. He will succeed CAT founder and CEO David Chiswell.

 

The board of directors of Paradigm Genetics has fired John Ryals, a co-founder of the company and its CEO and president. Paradigm of Research Triangle Park, NC, did not offer a reason for Ryals’ dismissal, but a company spokeswoman told BioInform’s sister publication GenomeWeb that there had been “some dysfunction in the relationship between him and the board and him and the management team.” CSO John Hamer will assume Ryals’ duties while the company searches for a replacement.

Filed under

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.